Humana Reports 26.2% Revenue Growth to $40.9 Billion in Q2 2026

Humana Inc. reported significant financial growth in its latest quarterly results, with total revenues reaching $40.9 billion for the three months ended June 30, 2026, a 26.2% increase from $32.4 billion in the same period last year. For the first half of 2026, revenues totaled $80.5 billion, up 24.8% from $64.5 billion in 2025. The company's net income attributable to Humana was $694 million, or $5.73 per diluted share, compared to $545 million, or $4.51 per diluted share, in the prior year. This growth was primarily driven by a substantial increase in premiums from Medicare Advantage and stand-alone prescription drug plans, reflecting a rise in membership and higher per-member premiums.

The company experienced a notable increase in its customer base, with total medical membership growing by 20.7% to approximately 17.9 million members as of June 30, 2026. Individual Medicare Advantage membership rose by 23.4%, while Medicare stand-alone PDP membership surged by 62.6%. This growth in membership contributed to a 26.4% increase in premiums revenue, which reached $38.8 billion in the second quarter of 2026, compared to $30.7 billion in the same quarter of 2025. The increase in premiums was supported by higher benchmark funding from the Centers for Medicare and Medicaid Services (CMS) and the direct subsidy from the Inflation Reduction Act.

In terms of operational efficiency, Humana's benefit ratio increased to 91.1% for the second quarter of 2026, up from 89.7% in the prior year, reflecting higher costs associated with new members and the impact of the 2026 Star Ratings headwind. Operating costs also rose, but the operating cost ratio improved to 9.8% from 11.0% in the previous year, indicating better administrative efficiency. The company recorded operating expenses of $39.5 billion for the quarter, a 26.3% increase from $31.3 billion in 2025.

Strategically, Humana completed the acquisition of MaxHealth, a primary care organization, for approximately $908 million in cash on February 13, 2026. This acquisition is expected to enhance Humana's integrated care delivery model, which aims to improve health outcomes and affordability for its members. The company also initiated a multi-year transformation program to realign its cost structure and operating model in response to macroeconomic pressures, resulting in charges of $56 million for the second quarter of 2026.

Looking ahead, Humana remains optimistic about its growth trajectory, driven by its integrated care delivery model and ongoing value creation initiatives. The company anticipates continued membership growth and improved financial performance, although it acknowledges potential challenges from regulatory changes and market conditions. As of June 30, 2026, Humana's cash and cash equivalents increased to $6.9 billion, up from $4.2 billion at the end of 2025, providing a solid liquidity position to support its strategic initiatives.